High prevalence of adeno-associated virus (AAV) type 2 rep DNA in cervical materials: AAV may be sexually transmitted

Virus Genes

Volumn 12, Issue 1, 1996, Pages 47-52

  Han, L ^a   Parmley, T H ^a   Keith, S ^a   Kozlowski, K J ^a   Smith, L J ^b   Hermonat, P L ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Adeno associated virus; Antioncogene; Cervical cancer; Rep78; Sexual transmission

Indexed keywords

BETA GLOBIN; ETHIDIUM BROMIDE; VIRUS DNA;

ADENO ASSOCIATED VIRUS; ARTICLE; CELL ONCOGENE; CLINICAL ARTICLE; CONTROLLED STUDY; DOT HYBRIDIZATION; FEMALE; HUMAN; HUMAN TISSUE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROEPIDEMIOLOGY; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER; VIRUS ONCOGENE;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS 2; ANIMALIA; CANCER VIRUS; DNA VIRUSES; PARVOVIRUS;

EID: 0029741729     PISSN: 09208569     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00370000     Document Type: Article

References (32)

1. Casto B.C., Atchinson R.W., and Hammon W.McD., Virology 18, 52-60, 1967.
2. Buller R.M., Janik J.E., Subring E.D., and Rose J.A., J Virol 40, 241-247, 1981.
3. Mayor H.D., Drake S., Stahmann J., and Mumford D.M., Am J Obstet Gynecol 126, 100-105, 1976.
4. Georg-Fries B., Biederlack S., Wolf J., and zur Hausen H., Virology 134, 64-71, 1984.
5. Kirchstein R.L., Smith K.O., and Peters E.A., Proc Soc Exp Biol Med 128, 670-675, 1968.
6. Mayor H.D., Houlditch G.S., and Mumford D.M., Nature 241, 44-46, 1973.
7. Cukor G., Blacklow N.R., Kibrick S., and Swan I.C., J Natl Cancer Inst 55, 957-960, 1975.
8. Ostrove J.M., Duckworth D.H., and Berns K.I., Virology 113, 521-533, 1981.
9. Bantel-Schaal U. and zur Hausen H., Virology 164, 64-74, 1989.
10. Hermonat P.L., Virology 172, 253-261, 1989.
11. Hermonat P.L., Cancer Res 51, 3373-3377, 1991.
12. Hermonat P.L., Virology 189, 329-333, 1992.
13. Hermonat P.L., Cancer Res 54, 2278-2281, 1994.
14. Hermonat P.L., Cancer Lett 81, 129-136, 1994.
15. Winocour E., et al., Virology 190, 316-329, 1990.
16. Walz C. and Schlehofer J.R., J Virol 66, 2990-3002, 1992.
17. Heilbronn R., Burkle A., Stephan S., and zur Hausen H., J Virol 64, 3012-3018, 1990.
18. Katz E. and Carter B.J., Cancer Res 46, 3023-3026, 1986.
19. Khleif S.N., Myers T., Carter B.J., and Trempe J.P., Virology 181, 738-741, 1991.
20. Schmitt J., Schlehofer J.R., Mergener K., Gissman L., and zur Hausen H., Virology 172, 73-81, 1989.
21. zur Hausen H., Cancer Res 49, 4677-4681, 1989.
22. Cullen A.P., Reid R., and Lorincz T.T., J Virol 65, 606-612, 1991.
23. Blacklow N.R., Hoggan M.D., and Rowe W.P., Proc Natl Acad Sci USA 55, 1410-1414, 1967.
24. Blacklow N.R., Hoggan M.D., Kapikian A.Z., Austin J.B., and Rowe W.P., J Epidemiol 8, 368-370, 1968.
25. Park W.P., Boucher D.W., Melnick J.L., Taber H., and Yow M.D., Infect Immun 2, 716-720, 1970.
26. Blacklow N.R., Hoggan M.D., Sereno M.S., Brandt C.P., Kin H.W., Parrot R.H., and Chanock R.M., Am J Epidemiol 94, 359-366, 1971.
27. Bantel-Schaal U. and zur Hausen H., Virology 134, 52-63, 1984.
28. Ferre F., Garduno F., and Peter J.B., Cancer Cells 7, 215-220, 1989.
29. Tobiasch E., Rabreau M., Geletneky K., Larue-Charlus S., Severin F., Becker N., and Schlehofer J.R., J Med Virol 44, 215-222, 1994.
30. Grossman Z., Mendelson E., Brok-Simoni F., Mileguir F., Leitner Y., Rechavi G., and Ramot B., J Gen Virol 73, 960-966, 1992.
31. McNab J.C.M., J Virol 68, 2525-2550, 1987.
32. Lipps B.V. and Mayor H.D., Infect Immun37, 200-204, 1982.